|
Your search for [subject]Vaccines returned 123 records. |
|
|
Sort by:
|
|
|
|
|
|
|
|
An advance market commitment for AIDS vaccines : accelerating the response from industry.
New York, N.Y.: International AIDS Vaccine Initiative, 2006.
Subject: Vaccines industry; AIDS vaccines; Vaccines; Market surveys.
|
|
|
|
|
|
|
|
|
|
|
|
|
Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
by Okada , M;
Subject: BACTERIAL PROTEINS; CHAPERONINS; DISEASE MODELS, ANIMAL; HAPLORHINI; INTERLEUKIN-12; LIPOSOMES; SENDAI VIRUS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA; VACCINES, SYNTHETIC.
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines 91 : modern approaches to new vaccines including the prevention of AIDS.
by Chanock, Robert M.; New York: Cold Spring Harbor Laboratory Press, 1991.
Subject: AIDS vaccines; Vaccines; Viral vaccines.
|
|
|
|
|
|
|
|
|
|
|
|
|
HerpesViruses weekly.
Birmingham, Ala.: Charles W. Henderson, 1998.
Subject: Herpesvirus diseases; Herpesvirus vaccines; Herpesvirus vaccines -- Industrial applications; Herpesviruses; Viral vaccines; Viral vaccines -- Industrial applications; Viruses; Health. -- galestne; Health; MAG (Magazine/Journal) -- galestne.
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccination against pregnancy : miracle or menace?.
by Richter, Judith.; Atlantic Highlands, N.J.: Zed Books, 1996.
Subject: Antifertility vaccines; Contraception, Immunological vaccines; Birth control -- Moral and ethical aspects.
|
|
|
|
|
|
|
|
|
|
|
|
|
Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial.
by Walsh, G. P.;
Subject: BACTERIAL VACCINES; IMMUNOTHERAPY, ACTIVE; MYCOBACTERIUM; PSORIASIS; SEVERITY OF ILLNESS INDEX; VACCINES, INACTIVATED.
|
|
|
|
|
|
|
|
|
|
|
|
|
Creating markets for new vaccines part I : rationale.
by Kremer, Michael.; Cambridge: National Bureau of Economic Research, 2000.
Subject: Vaccines -- Research -- Economic aspects; Vaccines industry -- Government policy; Vaccines -- Prices -- Government policy; Medical assistance -- Economic aspects -- Developing countries.
|
|
|
|
|
|
|
|
|
|
|
|
|
Creating markets for new vaccines part II : design issues.
by Kremer, Michael.; Cambridge: National Bureau of Economic Research, 2000.
Subject: Vaccines -- Research -- Economic aspects; Vaccines industry -- Government policy; Vaccines -- Prices -- Government policy; Medical assistance -- Economic aspects -- Developing countries.
|
|
|
|
|
|
|
|
|
|
|
|
|
Strategies in vaccine design.
by Ada, G. L.,; Austin: R.G. Landes, 1994.
Subject: Synthetic vaccines; Vaccines -- Design; Vaccines, Synthetic -- immunology; Immunity, Cellular -- immunology.
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine trial as "probe" to define the burden of pneumococcal pneumonia disease.
by Williams, Gail;
Subject: INCIDENCE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINES, CONJUGATE.
|
|
|
|
|
|
|
|
|
|
« Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next » |